PubRank

Michael G Alexandrakis

Author PubWeight™ 20.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease. Clin Chem Lab Med 2005 1.93
2 The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res 2002 1.08
3 Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest 2006 1.02
4 Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. J Interferon Cytokine Res 2006 0.92
5 The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome. BMC Pulm Med 2004 0.92
6 Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production. J Autoimmun 2005 0.89
7 Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma. Hematol Oncol 2011 0.87
8 Acquired inhibitors to coagulation factors in patients with gastrointestinal diseases. Eur J Gastroenterol Hepatol 2002 0.84
9 Serum levels of angiopoietin-2 are associated with the growth of multiple myeloma. Cancer Invest 2013 0.81
10 Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J Hepatol 2003 0.81
11 Miliary tuberculosis with no pulmonary involvement in myelodysplastic syndromes: a curable, yet rarely diagnosed, disease: case report and review of the literature. Ann Clin Microbiol Antimicrob 2008 0.81
12 Histological expression of angiogenic factors: VEGF, PDGFRalpha, and HIF-1alpha in Hodgkin lymphoma. Pathol Res Pract 2008 0.80
13 Clinical significance of interleukin-22 in multiple myeloma. Hematology 2014 0.78
14 Th1 cytokine pattern (IL-12 and IL-18) in bronchoalveolar lavage fluid (BALF) before and after treatment with interferon gamma-1b (IFN-gamma-1b) or colchicine in patients with idiopathic pulmonary fibrosis (IPF/UIP). Sarcoidosis Vasc Diffuse Lung Dis 2004 0.78
15 Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J Hepatol 2005 0.78
16 Prognostic impact of angiopoietin-2 in multiple myeloma. J Cancer Res Clin Oncol 2014 0.77
17 Investigation of IL-18 and IL-12 in induced sputum of patients with IPF before and after treatment with interferon gamma-1b. Sarcoidosis Vasc Diffuse Lung Dis 2005 0.77
18 The relationship between soluble receptor of interleukin-6 with angiogenic cytokines and proliferation markers in multiple myeloma. Tumour Biol 2012 0.77
19 Cytokine network in the pathogenesis of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2005 0.76
20 Mast cells influence the proliferation rate of myeloma plasma cells. Cancer Invest 2015 0.76
21 Increased serum levels of MIP-1alpha correlate with bone disease and angiogenic cytokines in patients with multiple myeloma. Med Oncol 2013 0.75
22 Coexistence of plasma cell dyscrasia with prefibrotic stage of primary myelofibrosis: a case report. ISRN Hematol 2011 0.75
23 The Impact of Mast Cell Density on the Progression of Bone Disease in Multiple Myeloma Patients. Int Arch Allergy Immunol 2016 0.75
24 Activated Protein C-Resistance Determination and Vascular Access Thrombosis in Populations with High Prevalence of Factor V Leiden. Nephron 2015 0.75
25 Kikuchi's disease: a benign cause of fever and cervical lymphadenopathy. Eur J Intern Med 2005 0.75
26 Elevated serum angiogenin in multiple myeloma. Hematol J 2003 0.75
27 Positive correlation between bone marrow mast cell density and ISS prognostic index in patients with multiple myeloma. Leuk Res 2013 0.75
28 The significance of non correlation between interleukin-8 serum levels with bone marrow microvascular density in patients with myeloma multiple. Pathol Oncol Res 2013 0.75
29 Blockade of platelet alpha2B-adrenergic receptors: a novel antiaggregant mechanism. Int J Cardiol 2013 0.75